Global Onychomycosis (Tinea Unguium) Drug Market Insights and Forecast to 2027

    • ID: AR3067393
    • 09 June, 2021
    • Other
    • Region: Global
    • 111 Pages
    • QYResearch

    1 Study Coverage

    • 1.1 Onychomycosis (Tinea Unguium) Drug Product Introduction
    • 1.2 Market by Type
      • 1.2.1 Global Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Type
      • 1.4.2 Oral Medication
      • 1.4.3 External Medicine
    • 1.3 Market by Application
      • 1.3.1 Global Onychomycosis (Tinea Unguium) Drug Market Size Growth Rate by Application
      • 1.3.2 Age under 18
      • 1.3.3 Age 18-50
      • 1.3.4 Age above 50
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Executive Summary

    • 2.1 Global Onychomycosis (Tinea Unguium) Drug Sales Estimates and Forecasts 2016-2027
    • 2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Estimates and Forecasts 2016-2027
    • 2.3 Global Onychomycosis (Tinea Unguium) Drug Revenue by Region: 2016 VS 2021 VS 2027
    • 2.4 Global Top Onychomycosis (Tinea Unguium) Drug Regions by Sales
      • 2.4.1 Global Top Onychomycosis (Tinea Unguium) Drug Regions by Sales (2016-2021)
      • 2.4.2 Global Top Onychomycosis (Tinea Unguium) Drug Regions by Sales (2022-2027)
    • 2.5 Global Top Onychomycosis (Tinea Unguium) Drug Regions by Revenue
      • 2.5.1 Global Top Onychomycosis (Tinea Unguium) Drug Regions by Revenue (2016-2021)
      • 2.5.2 Global Top Onychomycosis (Tinea Unguium) Drug Regions by Revenue (2022-2027)
    • 2.6 North America
    • 2.7 Europe
    • 2.8 Asia-Pacific
    • 2.9 Latin America
    • 2.10 Middle East & Africa

    3 Competition by Manufacturers

    • 3.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Manufacturers
      • 3.1.1 Global Top Onychomycosis (Tinea Unguium) Drug Manufacturers by Sales (2016-2021)
      • 3.1.2 Global Top Onychomycosis (Tinea Unguium) Drug Manufacturers Market Share by Sales (2016-2021)
      • 3.1.3 Global Top 10 and Top 5 Companies by Onychomycosis (Tinea Unguium) Drug Sales in 2020
    • 3.2 Global Onychomycosis (Tinea Unguium) Drug Revenue by Manufacturers
      • 3.2.1 Global Top Onychomycosis (Tinea Unguium) Drug Manufacturers by Revenue (2016-2021)
      • 3.2.2 Global Top Onychomycosis (Tinea Unguium) Drug Manufacturers Market Share by Revenue (2016-2021)
      • 3.2.3 Global Top 10 and Top 5 Companies by Onychomycosis (Tinea Unguium) Drug Revenue in 2020
    • 3.3 Global Onychomycosis (Tinea Unguium) Drug Sales Price by Manufacturers
    • 3.4 Analysis of Competitive Landscape
      • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      • 3.4.3 Global Onychomycosis (Tinea Unguium) Drug Manufacturers Geographical Distribution
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Type
      • 4.1.1 Global Onychomycosis (Tinea Unguium) Drug Historical Sales by Type (2016-2021)
      • 4.1.2 Global Onychomycosis (Tinea Unguium) Drug Forecasted Sales by Type (2022-2027)
      • 4.1.3 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2016-2027)
    • 4.2 Global Onychomycosis (Tinea Unguium) Drug Revenue by Type
      • 4.2.1 Global Onychomycosis (Tinea Unguium) Drug Historical Revenue by Type (2016-2021)
      • 4.2.2 Global Onychomycosis (Tinea Unguium) Drug Forecasted Revenue by Type (2022-2027)
      • 4.2.3 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2016-2027)
    • 4.3 Global Onychomycosis (Tinea Unguium) Drug Price by Type
      • 4.3.1 Global Onychomycosis (Tinea Unguium) Drug Price by Type (2016-2021)
      • 4.3.2 Global Onychomycosis (Tinea Unguium) Drug Price Forecast by Type (2022-2027)

    5 Market Size by Application

    • 5.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Application
      • 5.1.1 Global Onychomycosis (Tinea Unguium) Drug Historical Sales by Application (2016-2021)
      • 5.1.2 Global Onychomycosis (Tinea Unguium) Drug Forecasted Sales by Application (2022-2027)
      • 5.1.3 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2016-2027)
    • 5.2 Global Onychomycosis (Tinea Unguium) Drug Revenue by Application
      • 5.2.1 Global Onychomycosis (Tinea Unguium) Drug Historical Revenue by Application (2016-2021)
      • 5.2.2 Global Onychomycosis (Tinea Unguium) Drug Forecasted Revenue by Application (2022-2027)
      • 5.2.3 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Application (2016-2027)
    • 5.3 Global Onychomycosis (Tinea Unguium) Drug Price by Application
      • 5.3.1 Global Onychomycosis (Tinea Unguium) Drug Price by Application (2016-2021)
      • 5.3.2 Global Onychomycosis (Tinea Unguium) Drug Price Forecast by Application (2022-2027)

    6 North America

    • 6.1 North America Onychomycosis (Tinea Unguium) Drug Market Size by Type
      • 6.1.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2027)
      • 6.1.2 North America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2027)
    • 6.2 North America Onychomycosis (Tinea Unguium) Drug Market Size by Application
      • 6.2.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2027)
      • 6.2.2 North America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2027)
    • 6.3 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country
      • 6.3.1 North America Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2027)
      • 6.3.2 North America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2027)
      • 6.3.3 U.S.
      • 6.3.4 Canada

    7 Europe

    • 7.1 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Type
      • 7.1.1 Europe Onychomycosis (Tinea Unguium) Drug Sales by Type (2017-2027)
      • 7.1.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Type (2017-2027)
    • 7.2 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Application
      • 7.2.1 Europe Onychomycosis (Tinea Unguium) Drug Sales by Application (2017-2027)
      • 7.2.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Application (2017-2027)
    • 7.3 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country
      • 7.3.1 Europe Onychomycosis (Tinea Unguium) Drug Sales by Country (2017-2027)
      • 7.3.2 Europe Onychomycosis (Tinea Unguium) Drug Revenue by Country (2017-2027)
      • 7.3.3 Germany
      • 7.3.4 France
      • 7.3.5 U.K.
      • 7.3.6 Italy
      • 7.3.7 Russia

    8 Asia Pacific

    • 8.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Type
      • 8.1.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Type (2018-2027)
      • 8.1.2 Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Type (2018-2027)
    • 8.2 Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Application
      • 8.2.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Application (2018-2027)
      • 8.2.2 Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Application (2018-2027)
    • 8.3 Asia Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region
      • 8.3.1 Asia Pacific Onychomycosis (Tinea Unguium) Drug Sales by Region (2018-2027)
      • 8.3.2 Asia Pacific Onychomycosis (Tinea Unguium) Drug Revenue by Region (2018-2027)
      • 8.3.3 China
      • 8.3.4 Japan
      • 8.3.5 South Korea
      • 8.3.6 India
      • 8.3.7 Australia
      • 8.3.8 Taiwan
      • 8.3.9 Indonesia
      • 8.3.10 Thailand
      • 8.3.11 Malaysia
      • 8.3.12 Philippines

    9 Latin America

    • 9.1 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Type
      • 9.1.1 Latin America Onychomycosis (Tinea Unguium) Drug Sales by Type (2019-2027)
      • 9.1.2 Latin America Onychomycosis (Tinea Unguium) Drug Revenue by Type (2019-2027)
    • 9.2 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Application
      • 9.2.1 Latin America Onychomycosis (Tinea Unguium) Drug Sales by Application (2019-2027)
      • 9.2.2 Latin America Onychomycosis (Tinea Unguium) Drug Revenue by Application (2019-2027)
    • 9.3 Latin America Onychomycosis (Tinea Unguium) Drug Market Size by Country
      • 9.3.1 Latin America Onychomycosis (Tinea Unguium) Drug Sales by Country (2019-2027)
      • 9.3.2 Latin America Onychomycosis (Tinea Unguium) Drug Revenue by Country (2019-2027)
      • 9.3.3 Mexico
      • 9.3.4 Brazil
      • 9.3.5 Argentina

    6 Middle East and Africa

    • 6.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Type
      • 6.1.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Type (2016-2027)
      • 6.1.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Type (2016-2027)
    • 6.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Application
      • 6.2.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Application (2016-2027)
      • 6.2.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Application (2016-2027)
    • 6.3 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country
      • 6.3.1 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Sales by Country (2016-2027)
      • 6.3.2 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Revenue by Country (2016-2027)
      • 6.3.3 Turkey
      • 6.3.4 Saudi Arabia
      • 6.3.5 UAE

    11 Company Profiles

    • 11.1 Johnson and Johnson
      • 11.1.1 Johnson and Johnson Corporation Information
      • 11.1.2 Johnson and Johnson Overview
      • 11.1.3 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.1.4 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Product Description
      • 11.1.5 Johnson and Johnson Related Developments
    • 11.2 GSK
      • 11.2.1 GSK Corporation Information
      • 11.2.2 GSK Overview
      • 11.2.3 GSK Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.2.4 GSK Onychomycosis (Tinea Unguium) Drug Product Description
      • 11.2.5 GSK Related Developments
    • 11.3 Novartis
      • 11.3.1 Novartis Corporation Information
      • 11.3.2 Novartis Overview
      • 11.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.3.4 Novartis Onychomycosis (Tinea Unguium) Drug Product Description
      • 11.3.5 Novartis Related Developments
    • 11.4 Pfizer
      • 11.4.1 Pfizer Corporation Information
      • 11.4.2 Pfizer Overview
      • 11.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.4.4 Pfizer Onychomycosis (Tinea Unguium) Drug Product Description
      • 11.4.5 Pfizer Related Developments
    • 11.5 Valeant Pharma
      • 11.5.1 Valeant Pharma Corporation Information
      • 11.5.2 Valeant Pharma Overview
      • 11.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.5.4 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product Description
      • 11.5.5 Valeant Pharma Related Developments
    • 11.6 Kaken Pharmaceutical
      • 11.6.1 Kaken Pharmaceutical Corporation Information
      • 11.6.2 Kaken Pharmaceutical Overview
      • 11.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.6.4 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Description
      • 11.6.5 Kaken Pharmaceutical Related Developments
    • 11.7 Galderma
      • 11.7.1 Galderma Corporation Information
      • 11.7.2 Galderma Overview
      • 11.7.3 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.7.4 Galderma Onychomycosis (Tinea Unguium) Drug Product Description
      • 11.7.5 Galderma Related Developments
    • 11.8 Xiuzheng Pharmaceutical
      • 11.8.1 Xiuzheng Pharmaceutical Corporation Information
      • 11.8.2 Xiuzheng Pharmaceutical Overview
      • 11.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.8.4 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Description
      • 11.8.5 Xiuzheng Pharmaceutical Related Developments
    • 11.9 Letai
      • 11.9.1 Letai Corporation Information
      • 11.9.2 Letai Overview
      • 11.9.3 Letai Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.9.4 Letai Onychomycosis (Tinea Unguium) Drug Product Description
      • 11.9.5 Letai Related Developments
    • 11.10 Qilu Pharmaceutical
      • 11.10.1 Qilu Pharmaceutical Corporation Information
      • 11.10.2 Qilu Pharmaceutical Overview
      • 11.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.10.4 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product Description
      • 11.10.5 Qilu Pharmaceutical Related Developments
    • 11.1 Johnson and Johnson
      • 11.1.1 Johnson and Johnson Corporation Information
      • 11.1.2 Johnson and Johnson Overview
      • 11.1.3 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Sales, Price, Revenue and Gross Margin (2016-2021)
      • 11.1.4 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Product Description
      • 11.1.5 Johnson and Johnson Related Developments

    12 Value Chain and Sales Channels Analysis

    • 12.1 Onychomycosis (Tinea Unguium) Drug Value Chain Analysis
    • 12.2 Onychomycosis (Tinea Unguium) Drug Key Raw Materials
      • 12.2.1 Key Raw Materials
      • 12.2.2 Raw Materials Key Suppliers
    • 12.3 Onychomycosis (Tinea Unguium) Drug Production Mode & Process
    • 12.4 Onychomycosis (Tinea Unguium) Drug Sales and Marketing
      • 12.4.1 Onychomycosis (Tinea Unguium) Drug Sales Channels
      • 12.4.2 Onychomycosis (Tinea Unguium) Drug Distributors
    • 12.5 Onychomycosis (Tinea Unguium) Drug Customers

    13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

    • 13.1 Onychomycosis (Tinea Unguium) Drug Industry Trends
    • 13.2 Onychomycosis (Tinea Unguium) Drug Market Drivers
    • 13.3 Onychomycosis (Tinea Unguium) Drug Market Challenges
    • 13.4 Onychomycosis (Tinea Unguium) Drug Market Restraints

    14 Key Findings in The Global Onychomycosis (Tinea Unguium) Drug Study

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Author Details

      Onychomycosis (Tinea Unguium) Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Onychomycosis (Tinea Unguium) Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

      Segment by Type
      Oral Medication
      External Medicine

      Segment by Application
      Age under 18
      Age 18-50
      Age above 50

      By Company
      Johnson and Johnson
      GSK
      Novartis
      Pfizer
      Valeant Pharma
      Kaken Pharmaceutical
      Galderma
      Xiuzheng Pharmaceutical
      Letai
      Qilu Pharmaceutical

      By Region
      North America
      U.S.
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Taiwan
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia



      Summary:
      Onychomycosis (Tinea Unguium) Drug Market Research Report is about Onychomycosis (Tinea Unguium) Drug Industry study. Get complete Onychomycosis (Tinea Unguium) Drug market research report published after Market Study, Industrial Analysis with Trends & Statistics. Onychomycosis (Tinea Unguium) Drug Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED